HYSPAN 400MG ORAL POWDER

Land: Irland

Språk: engelsk

Kilde: HPRA (Health Products Regulatory Authority)

Aktiv ingrediens:

NEOMYCIN SULFATE

Tilgjengelig fra:

Cross Vetpharm Group Limited

ATC-kode:

QA07AA01

INN (International Name):

NEOMYCIN SULFATE

Dosering :

400 Milligram

Legemiddelform:

Oral Powder

Resept typen:

POM: Prescription Only Medicine as defined in relevant national legislation

Terapeutisk gruppe:

Bovine

Terapeutisk område:

neomycin

Indikasjoner:

Antibacterial

Autorisasjon status:

Authorised

Autorisasjon dato:

2007-01-22

Preparatomtale

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Hyspan 400mg Oral Powder
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 100g sachet contains:
ACTIVE SUBSTANCE
Neomycin Sulphate
400mg
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Oral powder.
White to off-white free-flowing powder.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Calves.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of scour in calves mainly due to Escherichia coli
and Salmonella.
Specially formulated to combat
infection, dehydration and loss of electrolytes.
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active
ingredients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Withdraw all milk and milk replacer from scouring animals.
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_6_
_/_
_0_
_9_
_/_
_2_
_0_
_1_
_2_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_3_
_3_
_1_
_5_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Withdraw all milk and milk replacer from scouring animals.
Use of the product should be based on susceptibility testing of the
bacteria isolated from the animal. If this is not possible, therapy
should be based on local (regional, farm level) epidemiological
information about susceptibility of the target bacteria
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
MEDICINAL PRODUCT TO ANIMALS
None.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Non